Johnson & Johnson subsidiary Janssen Pharmaceuticals is being sued by a Texas man who claims the company’s type 2 diabetes drug Invokana caused him to develop ketoacidosis, a potentially life-threatening condition in which too much acid builds up in the blood. Arthur Portnoff, who filed his lawsuit in Philadelphia Court of Common Pleas, claims he began taking the drug in November 2014 and was hospitalized in February 2015 with ketoacidosis. He claims that Janssen knew the drug could cause serious injuries but failed to adequately warn patients or doctors of this risk. His complaint also states that Janssen did not ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.